1,811 results found

On December 19, 2024, FDA issued a new decision determining that the tirzepatide drug shortage was resolved. FDA initially added tirzepatide to the drug shortage list in December 2022, which allowed state-licensed.

In the rapidly changing landscape of healthcare, pharmacy benefit managers (PBMs) are increasingly under scrutiny for their significant influence on prescription drug pricing and patient access.

On May 8, 2025, the United States Food and Drug Administration (FDA) issued yet another warning advising consumers not to purchase or use any tianeptine products.

On June 18, 2020, the Supreme Court of the United States ("SCOTUS") issued a decision blocking an attempt by the Trump Administration to end the Deferred Action for Childhood Arrivals ("DACA") program...

The Department of Homeland Security, Customs and Border Protection (CBP), recently announced that it will no longer stamp passports of foreign nationals entering the United States at certain ports of entry.

In a recent Federal Circuit decision, Crocs, Inc. v. Effervescent, Inc., 2024 U.S.P.Q.2d 1757 (Fed. Cir. 2024), the court held that falsely claiming a product or product feature is patented can create a claim for...

In a closely watched case with major implications for the NFT (non-fungible token) industry, a jury in the United States District Court for the Southern District of New York...

Joseph Dougherty, Buchanan's CEO and managing director, talks about the firm's partnership with Carnegie Mellon University's Heinz College of Information Systems and Public Policy to develop

On this episode of Alternative Power Plays, Buchanan, Ingersoll, & Rooney attorneys and podcast hosts John Povilaitis and Alan Seltzer shift from the usual renewable...

On July 18, 2025, President Trump signed into law Public Law No: 119-27, the Guiding and Establishing National Innovation for U.S. Stablecoins Act, commonly referred to as the GENIUS Act.

U.S. manufacturers should pay close attention to potential changes that could lead to an increase in lower priced competition from China. In 2018 and 2019, the Trump administration placed 25% duties...

On July 10, 2024, Tungsten Parts Wyoming, Inc. (TPW) filed petitions requesting antidumping and countervailing duties on imports of certain tungsten shot from the People's Republic of China...

While much of the focus on inclusivity for the LGBTQ+ community happens during Pride Month in June, it's important to recognize and bring attention to the issues impacting the community throughout the year.

In September 1996, the Mental Health Parity Act was signed into law to address variations of annual and lifetime dollar limits for mental health benefits vs. medical and surgical.

Buchanan Ingersoll & Rooney and Avidity IP recently partnered for a webinar. The panelists – Todd Walters, Roger Lee and Jaskiranjit Kang, Ph.D. of Buchanan IP and Joeeta Murphy...

On December 21, the State Department released the long-awaited details of a previously announced pilot program that will allow qualified noncitizens to renew their H-1B nonimmigrant visas within the United States.

We were pleased to partner with the French American Chamber of Commerce to present a one-hour discussion that focused on the stakes of navigating the economic sanctions...